Wildlife Welfare: Horseshoe Crab Blood Harvest

Horseshoe crabs are harvested for their blue blood, which is used to test for bacterial contamination in pharmaceuticals, causing significant mortality and welfare concerns.

Key Facts

An estimated 500,000 horseshoe crabs are bled annually in the USA for pharmaceutical testing
Bleeding involves capturing, transporting and draining 30% of blood volume before release
Mortality rates from the bleeding process are estimated at 10-30% of bled animals
Synthetic alternatives (rFC) can replace horseshoe crab blood for endotoxin testing
Horseshoe crabs are important prey for migratory shorebirds including red knot, which has declined partly due to horseshoe crab harvest

Welfare Considerations

Horseshoe crab blood harvest causes stress, injury and mortality at scale. Animals are transported from their habitat, subjected to invasive bleeding procedures and returned in a weakened state. Beyond individual welfare, the ecosystem cascade through depletion of shorebird prey resources represents broader animal welfare harm. The availability of validated synthetic alternatives (rFC) makes continued horseshoe crab harvest an increasingly difficult ethical position to defend.

What You Can Do

Support campaigns for pharmaceutical industry adoption of synthetic rFC testing alternatives
Learn about horseshoe crab ecology and the shorebird dependence on their eggs
Donate to horseshoe crab and shorebird conservation organisations
Advocate for regulatory approval and adoption of rFC alternatives across pharmaceutical markets